Respiratory Pathogen Panel (RPP)

Upper respiratory infection is responsible for many life-threatening illnesses. The CDC National Center for Health Statistics reported flu and pneumonia to be the eighth leading cause of death in the US (2014 data). Because of the potential for harm and the possibility of contagion among patient populations, rapid results are critical to determining which virus or bacteria is responsible so that the illness can be contained.

Traditional methods of testing required valuable time (as much as 8-12 days) to detect pathogens, but recent improvements in testing technology mean quicker identification and better disease management.

PHS partner labs offer a user-friendly, advanced pathogen panel that can detect multiple respiratory infections, allowing providers to target the appropriate therapy sooner and eliminate unnecessary antibiotics.

Advantages of the Rapid Pathogen Panel:

  • Rapid Turnaround Time – 24 Hours After Receipt at Lab
  • Advanced Detection
  • Comprehensive Panel includes more than 20 Targets
  • Secure Specimen Collection Reduces Risk of Contamination
  • Cost Savings – No Unnecessary Antibiotics
Upper Respiratory Tract

Viral Targets

Bacterial Targets

  • Influenza A
  • Influenza A H1
  • Influenza A H3
  • Parainfluenza 1
  • Parainfluenza 2
  • Parainfluenza 3
  • Parainfluenza 4
  • Human Metapneumovirus (hMPV)
  • Human Rhinovirus / Enterovirus
  • Respiratory Syncytial Virus A (RSV A)
  • Respiratory Syncytial Virus B (RSV B)
  • Influenza A 2009 H1N1
  • Influenza B
  • Coronavirus NL63
  • Coronavirus OC43
  • Human Bocavirus
  • Adenovirus
  • Coronavirus HKU1
  • Coronavirus 229E
  • Chlamydophila Pneumoniae
  • Mycoplasma Pneomoniae